Your browser doesn't support javascript.
loading
Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials.
Agostinetto, Elisa; Eiger, Daniel; Lambertini, Matteo; Ceppi, Marcello; Bruzzone, Marco; Pondé, Noam; Plummer, Chris; Awada, Ahmad H; Santoro, Armando; Piccart-Gebhart, Martine; de Azambuja, Evandro.
Afiliación
  • Agostinetto E; Academic Trials Promoting Team, Institut Jules Bordet, L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center - IRCCS, Humanitas Cancer Center, via Manzoni 56, 20089, Rozzano, Milan, Italy; Humanitas University, Depart
  • Eiger D; Academic Trials Promoting Team, Institut Jules Bordet, L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Ceppi M; Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Bruzzone M; Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Pondé N; Clinical Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil.
  • Plummer C; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
  • Awada AH; Oncology Department, Institut Jules Bordet, Brussels, Belgium.
  • Santoro A; Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center - IRCCS, Humanitas Cancer Center, via Manzoni 56, 20089, Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, via Rita Levi Montalcini 4, 20090 Pieve Emanuele - Milan, Italy.
  • Piccart-Gebhart M; Oncology Department, Institut Jules Bordet, Brussels, Belgium.
  • de Azambuja E; Academic Trials Promoting Team, Institut Jules Bordet, L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
Eur J Cancer ; 148: 76-91, 2021 05.
Article en En | MEDLINE | ID: mdl-33740500
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Cardiotoxicidad / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Cardiotoxicidad / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article